NASDAQ · BCRX

BioCryst Pharmaceuticals, Inc.

Healthcare · Biotechnology

$7.63

Down-$0.06 (-0.78%)

Updated Nov 10, 2026, 7:52 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 1.6B
P/E ratio: -181.47
Dividend yield: 0.00%
52-week range: $7.38 – $11.22
Volume: 5.52M
Avg. volume: 4.95M

Price performance · BCRX

BCRX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 9, 2026

Last close: $7.63
Period change: -8.73%
Period low: $7.63
Period high: $8.57

Daily close

View OHLC price history

BCRX OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Nov 9, 2026	$7.76	$7.775	$7.54	$7.63	5.52M
Nov 6, 2026	$7.81	$7.83	$7.38	$7.69	5.21M
Nov 5, 2026	$8.275	$8.275	$7.415	$7.63	15.36M
Nov 4, 2026	$8.425	$8.86	$8.105	$8.24	10.23M
Nov 3, 2026	$8.23	$8.62	$8.1893	$8.57	6.53M
Nov 2, 2026	$8.49	$8.52	$8.22	$8.245	4.09M
Oct 30, 2026	$8.55	$8.6172	$8.38	$8.47	3.53M
Oct 29, 2026	$8.45	$8.56	$8.39	$8.52	4.52M
Oct 28, 2026	$8.05	$8.445	$8.005	$8.37	3.94M
Oct 27, 2026	$7.925	$8.12	$7.81	$8.10	8.75M
Oct 26, 2026	$7.69	$8.00	$7.66	$7.88	4.38M
Oct 23, 2026	$7.71	$7.7642	$7.52	$7.65	2.75M
Oct 22, 2026	$7.78	$7.88	$7.66	$7.78	4.81M
Oct 21, 2026	$8.04	$8.05	$7.73	$7.75	5.03M
Oct 20, 2026	$8.11	$8.13	$7.84	$7.94	8.46M
Oct 19, 2026	$7.77	$8.09	$7.77	$8.07	9.77M
Oct 16, 2026	$7.96	$8.015	$7.74	$7.79	4.43M
Oct 15, 2026	$8.105	$8.24	$7.945	$8.02	4.5M
Oct 14, 2026	$8.02	$8.18	$7.97	$8.05	5.65M
Oct 13, 2026	$8.22	$8.315	$8.06	$8.07	3.04M
Oct 12, 2026	$8.49	$8.55	$8.24	$8.36	3.47M

Latest BCRX news

The latest Smart Investors Daily articles mentioning BCRX.

analystNov 5, 2026

Wedbush Reiterates Outperform Rating on BioCryst Pharmaceuticals, Inc. (BCRX)

earningsNov 4, 2026

BioCryst Pharma (BCRX) Beats Q3 Earnings Estimates by $0.03

priceOct 7, 2026

BioCryst Pharmaceuticals, Inc. (BCRX) Surges 5.6% on Heavy Volume

Latest BCRX news

The latest Smart Investors Daily articles mentioning BCRX.

BCRX research

SEC Filings

Recent regulatory filings and source documents.

SEC filing history

Open a filing to view the original source document.

BCRX SEC filings
Filed	Form	Description	Accepted	Document
Nov 4, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Nov 4, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Sep 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 5, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Aug 5, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 4, 2026	8-K/A	Form 8-K/A - Current report: [Amend] - Item 2.05	—	Open source
Jun 29, 2026	8-K	Form 8-K - Current report - Item 2.05 Item 7.01 Item 9.01	—	Open source
May 6, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
May 4, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 9.01	—	Open source
Apr 23, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Feb 26, 2026	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Jan 23, 2026	8-K/A	Form 8-K/A - Current report: [Amend] - Item 5.02	—	Open source
Jan 23, 2026	8-K	Form 8-K - Current report - Item 1.01 Item 2.01 Item 2.03 Item 7.01 Item 9.01	—	Open source
Jan 12, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 8.01 Item 9.01	—	Open source
Jan 9, 2026	8-K	Form 8-K - Current report - Item 7.01	—	Open source
Dec 11, 2025	8-K	Form 8-K - Current report - Item 5.02	—	Open source
Dec 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 3, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Dec 2, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 2, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 2, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Nov 20, 2025	S-4	Form S-4 - Registration of securities, business combinations	—	Open source
Nov 17, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Nov 4, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 3, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Oct 14, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 2.02 Item 5.02 Item 8.01 Item 9.01	—	Open source
Oct 1, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01	—	Open source
Sep 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 15, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 12, 2025	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans	—	Open source
Aug 11, 2025	8-K	Form 8-K - Current report - Item 5.02	—	Open source
Aug 5, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 4, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Jul 31, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01	—	Open source
Jul 28, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01	—	Open source
Jun 30, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 9.01	—	Open source
Jun 27, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Jun 25, 2025	8-K	Form 8-K - Current report - Item 8.01	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source

Filed

Form

Description

Accepted

Document

Nov 4, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Sep 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 5, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 4, 2026

8-K/A

Form 8-K/A - Current report: [Amend] - Item 2.05

—

Open source

Jun 29, 2026

8-K

Form 8-K - Current report - Item 2.05 Item 7.01 Item 9.01

—

Open source

May 6, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

May 4, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 9.01

—

Open source

Apr 23, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Feb 26, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Jan 23, 2026

8-K/A

Form 8-K/A - Current report: [Amend] - Item 5.02

—

Open source

Jan 23, 2026

8-K

Form 8-K - Current report - Item 1.01 Item 2.01 Item 2.03 Item 7.01 Item 9.01

—

Open source

Jan 12, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 8.01 Item 9.01

—

Open source

Jan 9, 2026

8-K

Form 8-K - Current report - Item 7.01

—

Open source

Dec 11, 2025

8-K

Form 8-K - Current report - Item 5.02

—

Open source

Dec 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 3, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Dec 2, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 2, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 2, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Nov 20, 2025

S-4

Form S-4 - Registration of securities, business combinations

—

Open source

Nov 17, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 3, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Oct 14, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 2.02 Item 5.02 Item 8.01 Item 9.01

—

Open source

Oct 1, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01

—

Open source

Sep 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 15, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 12, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

—

Open source

Aug 11, 2025

8-K

Form 8-K - Current report - Item 5.02

—

Open source

Aug 5, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 4, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Jul 31, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01

—

Open source

Jul 28, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01

—

Open source

Jun 30, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 9.01

—

Open source

Jun 27, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Jun 25, 2025

8-K

Form 8-K - Current report - Item 8.01

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Wedbush Reiterates Outperform Rating on BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharma (BCRX) Beats Q3 Earnings Estimates by $0.03

BioCryst Pharmaceuticals, Inc. (BCRX) Surges 5.6% on Heavy Volume

Featured By

Wedbush Reiterates Outperform Rating on BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharma (BCRX) Beats Q3 Earnings Estimates by $0.03

BioCryst Pharmaceuticals, Inc. (BCRX) Surges 5.6% on Heavy Volume